<VariationArchive VariationID="2597" VariationName="NM_000126.4(ETFA):c.963+1del" VariationType="Deletion" Accession="VCV000002597" Version="5" RecordType="classified" NumberOfSubmissions="5" NumberOfSubmitters="5" DateLastUpdated="2024-02-04" DateCreated="2013-04-04" MostRecentSubmission="2023-12-30">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="17636" VariationID="2597">
      <GeneList>
        <Gene Symbol="ETFA" FullName="electron transfer flavoprotein subunit alpha" GeneID="2108" HGNC_ID="HGNC:3481" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>15q24.2-24.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="15" Accession="NC_000015.10" start="76215353" stop="76311469" display_start="76215353" display_stop="76311469" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="15" Accession="NC_000015.9" start="76508627" stop="76603809" display_start="76508627" display_stop="76603809" Strand="-" />
          </Location>
          <OMIM>608053</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000126.4(ETFA):c.963+1del</Name>
      <CanonicalSPDI>NC_000015.10:76225847:CC:C</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>15q24.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="15" Accession="NC_000015.10" start="76225848" stop="76225848" display_start="76225848" display_stop="76225848" variantLength="1" positionVCF="76225847" referenceAlleleVCF="AC" alternateAlleleVCF="A" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="15" Accession="NC_000015.9" start="76518189" stop="76518189" display_start="76518189" display_stop="76518189" variantLength="1" positionVCF="76518188" referenceAlleleVCF="AC" alternateAlleleVCF="A" />
      </Location>
      <HGVSlist>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000126.3" sequenceAccession="NM_000126" sequenceVersion="3" change="c.963+1delG">
            <Expression>NM_000126.3:c.963+1delG</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000015.9" sequenceAccession="NC_000015" sequenceVersion="9" change="g.76518190del" Assembly="GRCh37">
            <Expression>NC_000015.9:g.76518190del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_007077.2" sequenceAccession="NG_007077" sequenceVersion="2" change="g.90622del">
            <Expression>NG_007077.2:g.90622del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001127716.2" sequenceAccession="NM_001127716" sequenceVersion="2" change="c.816+1del">
            <Expression>NM_001127716.2:c.816+1del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001575" Type="splice donor variant" DB="SO" />
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000015.10" sequenceAccession="NC_000015" sequenceVersion="10" change="g.76225849del" Assembly="GRCh38">
            <Expression>NC_000015.10:g.76225849del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000126.4" sequenceAccession="NM_000126" sequenceVersion="4" change="c.963+1del" MANESelect="true">
            <Expression>NM_000126.4:c.963+1del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001575" Type="splice donor variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="608053.0005" DB="OMIM" />
        <XRef Type="rs" ID="746488455" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000126.4(ETFA):c.963+1del AND Glutaric acidemia IIa" Accession="RCV000002715" Version="2">
        <ClassifiedConditionList TraitSetID="8071">
          <ClassifiedCondition DB="MedGen" ID="C3278154">Glutaric acidemia IIa</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2003-07-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000126.4(ETFA):c.963+1del AND Multiple acyl-CoA dehydrogenase deficiency" Accession="RCV002496235" Version="4">
        <ClassifiedConditionList TraitSetID="3248">
          <ClassifiedCondition DB="MedGen" ID="C0268596">Multiple acyl-CoA dehydrogenase deficiency</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, conflicting classifications</ReviewStatus>
            <Description DateLastEvaluated="2023-10-06" SubmissionCount="3">Conflicting interpretations of pathogenicity</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000126.4(ETFA):c.963+1del AND not specified" Accession="RCV003155011" Version="1">
        <ClassifiedConditionList TraitSetID="9590">
          <ClassifiedCondition DB="MedGen" ID="CN169374">not specified</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-02-23" SubmissionCount="1">Uncertain significance</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-10-06" NumberOfSubmissions="5" NumberOfSubmitters="5" DateCreated="2013-04-04" MostRecentSubmission="2023-12-30">
        <ReviewStatus>criteria provided, conflicting classifications</ReviewStatus>
        <Description>Conflicting classifications of pathogenicity</Description>
        <Explanation DataSource="ClinVar" Type="public">Pathogenic(1); Likely pathogenic(1); Uncertain significance(2)</Explanation>
        <Citation Type="general">
          <ID Source="PubMed">12815589</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">16510302</ID>
        </Citation>
        <Comment DataSource="ClinVar" Type="public">Pathogenic(1); Likely pathogenic(1); Uncertain significance(2)</Comment>
        <DescriptionHistory Dated="2023-02-02">
          <Description>Likely pathogenic</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2022-12-31">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="9590" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="16789" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not specified</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">AllHighlyPenetrant</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not specified' was created for use in ClinVar so that submitters can convey the concept that a variant is benign, likely benign, or of uncertain significance for an unspecified set of disorders.  This usage was introduced in 2014 to replace AllHighlyPenetrant.</Attribute>
              </AttributeSet>
              <XRef ID="CN169374" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="8071" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="16188" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">ETFA deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Glutaric acidemia IIa</ElementValue>
                <XRef ID="MONDO:0700073" DB="MONDO" />
              </Name>
              <XRef ID="C3278154" DB="MedGen" />
              <XRef ID="MONDO:0700073" DB="MONDO" />
            </Trait>
          </TraitSet>
          <TraitSet ID="3248" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5563" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Glutaric acidemia type II</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Glutaric acidemia type 2</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">GA 2</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">GA II</ElementValue>
                <XRef Type="MIM" ID="231680" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Ethylmalonic-adipicaciduria</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Glutaric aciduria, type 2</ElementValue>
                <XRef ID="Glutaric+Acidemia+II/3111" DB="Genetic Alliance" />
                <XRef ID="22886006" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Multiple acyl-CoA dehydrogenase deficiency</ElementValue>
                <XRef ID="MONDO:0009282" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">EMA</ElementValue>
                <XRef Type="MIM" ID="231680" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">MADD</ElementValue>
                <XRef Type="MIM" ID="231680" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Multiple acyl-CoA dehydrogenase deficiency (MADD) represents a clinical spectrum in which presentations can be divided into type I (neonatal onset with congenital anomalies), type II (neonatal onset without congenital anomalies), and type III (late onset). Individuals with type I or II MADD typically become symptomatic in the neonatal period with severe metabolic acidosis, which may be accompanied by profound hypoglycemia and hyperammonemia. Many affected individuals die in the newborn period despite metabolic treatment. In those who survive the neonatal period, recurrent metabolic decompensation resembling Reye syndrome and the development of hypertrophic cardiomyopathy can occur. Congenital anomalies may include dysmorphic facial features, large cystic kidneys, hypospadias and chordee in males, and neuronal migration defects (heterotopias) on brain MRI. Individuals with type III MADD, the most common presentation, can present from infancy to adulthood. The most common symptoms are muscle weakness, exercise intolerance, and/or muscle pain, although metabolic decompensation with episodes of rhabdomyolysis can also be seen. Rarely, individuals with late-onset MADD (type III) may develop severe sensory neuropathy in addition to proximal myopathy.</Attribute>
                <XRef ID="NBK558236" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="6523" />
                <XRef ID="6523" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">32550677</ID>
                <ID Source="BookShelf">NBK558236</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2022">
                <URL>https://www.acmg.net/PDFLibrary/Glutaric-Aciduria-Type-2-ACT-Sheet.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Newborn Screening ACT Sheet, Elevated C4 and C5 +/- Other Acylcarnitines, Glutaric Acidemia II (GA-II) (MADD), 2022</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG Algorithm,">
                <URL>https://www.acmg.net/PDFLibrary/C4-C5-Elevated-Algorithm.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Algorithm, Glutaric Acidemia II (GA-II)/ MADD, Riboflavin Metabolism Disorder, Ethylmalonic Encephalopathy: C4 and C5 elevated +/- other elevated acylcarnitines (AC), 2022</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2021">
                <URL>https://www.acmg.net/PDFLibrary/C8-C6-C10.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Newborn Screening ACT Sheet, Elevated C8 with Lesser Elevations of C6 and C10 Acylcarnitine, Medium-Chain Acyl-CoA Dehydrogenase (MCAD) Deficiency, 2021</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG Algorithm, 2021">
                <URL>https://www.acmg.net/PDFLibrary/C8-C6-C10-Algorithm.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Algorithm, C8 Elevated + Lesser Elevations of C6 and C10, 2021</CitationText>
              </Citation>
              <XRef ID="26791" DB="Orphanet" />
              <XRef ID="C0268596" DB="MedGen" />
              <XRef ID="MONDO:0009282" DB="MONDO" />
              <XRef Type="MIM" ID="231680" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="22873" SubmissionDate="2011-07-27" DateLastUpdated="2013-04-04" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="608053.0005_GLUTARIC ACIDEMIA IIA" title="ETFA, IVS11DS, 1-BP DEL, +1G _GLUTARIC ACIDEMIA IIA" />
        <ClinVarAccession Accession="SCV000022873" DateUpdated="2013-04-04" DateCreated="2013-04-04" Type="SCV" Version="1" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2003-07-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a Belgian infant with glutaric acidemia IIA (231680) of the clinical form II (neonatal onset without congenital anomalies), Olsen et al. (2003) found compound heterozygosity for 2 mutations in the ETFA gene: the thr266-to-met mutation (T266M; 608053.0002) in exon 9 and a 1-bp deletion of the consensus G at the 5-prime donor splice site of intron 11 (IVS11+1delG), resulting in an 81-bp deletion in the cDNA and deletion of thr295 to lys321 in the protein.</Attribute>
              <Citation>
                <ID Source="PubMed">12815589</ID>
              </Citation>
              <XRef DB="OMIM" ID="231680" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ETFA" />
          </GeneList>
          <Name>ETFA, IVS11DS, 1-BP DEL, +1G</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">IVS11DS, 1-BP DEL, +1G</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="608053.0005" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">GLUTARIC ACIDEMIA IIA</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="6131508" SubmissionDate="2023-01-06" DateLastUpdated="2023-02-07" DateCreated="2023-02-07">
        <ClinVarSubmissionID localKey="4925308|MedGen:C0268596" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003443024" DateUpdated="2023-02-07" DateCreated="2023-02-07" Type="SCV" Version="1" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-02-04">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Uncertain significance</GermlineClassification>
          <Citation>
            <ID Source="PubMed">12815589</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">12815589</ID>
          </Citation>
          <Comment>This sequence change affects a splice site in intron 11 of the ETFA gene. RNA analysis indicates that disruption of this splice site induces altered splicing and likely results in a shortened protein product. This variant is present in population databases (rs746488455, gnomAD 0.004%). Disruption of this splice site has been observed in individual(s) with multiple Acyl-CoA dehydrogenase deficiency (PMID: 12815589). This variant is also known as IVS11+1Gdel. Studies have shown that disruption of this splice site results in skipping of exon 11, but is expected to preserve the integrity of the reading-frame (PMID: 12815589). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ETFA" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000015.9:g.76518189del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0268596" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12508014</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5463935" SubmissionDate="2022-12-13" DateLastUpdated="2022-12-31" DateCreated="2022-12-31">
        <ClinVarSubmissionID localKey="NM_000126.4:c.963+1del|OMIM:231680" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002810367" DateUpdated="2022-12-31" DateCreated="2022-12-31" Type="SCV" Version="1" SubmitterName="Fulgent Genetics, Fulgent Genetics" OrgID="500105" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-05-02">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000126.4:c.963+1del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="231680" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12390657</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7183343" SubmissionDate="2023-03-16" DateLastUpdated="2023-03-26" DateCreated="2023-03-26">
        <ClinVarSubmissionID localKey="NM_000126.3:c.963+1delG|MedGen:CN169374" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003845135" DateUpdated="2023-03-26" DateCreated="2023-03-26" Type="SCV" Version="1" SubmitterName="Women's Health and Genetics/Laboratory Corporation of America, LabCorp" OrgID="500026" OrganizationCategory="laboratory" OrgAbbreviation="WHG-LC" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-02-23">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Uncertain significance</GermlineClassification>
          <Citation>
            <ID Source="PubMed">16510302</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">12815589</ID>
          </Citation>
          <Comment>Variant summary: ETFA c.963+1delG is located in a canonical splice-site and is predicted to affect mRNA splicing resulting in a significantly altered protein due to either exon skipping, shortening, or inclusion of intronic material. Several computational tools predict a significant impact on normal splicing: Four predict the variant abolishes the canonical 5 splicing donor site. Three predict the variant creates a 5donor site. At least one publication reports experimental evidence that this variant results in skipping of exon 11 (example: Olsen_2003). This splice site alteration is predicted to preserve the integrity of the reading frame and introduces a premature stop at p.322 leading to a truncated protein. Truncations downstream of this position have not been classified as pathogenic by our laboratory or in ClinVar. The variant allele was found at a frequency of 1.2e-05 in 251340 control chromosomes (gnomAD). c.963+1delG has been reported in the literature in individuals affected with Glutaric Aciduria (examples: Olson_2003 and Schiff_2006). Multiple publication reports experimental evidence evaluating an impact on protein expression, however, does not allow convincing conclusions about the variant effect (example: Olson_2003 and Schiff_2006). Two clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 and classified the variant as likely pathogenic, and as uncertain significance. Based on the evidence outlined above, the variant was classified as VUS-possibly pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">LabCorp Variant Classification Summary - May 2015</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/rtxspsnt/labcorp_variant_classification_method_-_may_2015.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ETFA" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000126.3:c.963+1delG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN169374" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12956415</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7841394" SubmissionDate="2023-12-07" DateLastUpdated="2023-12-30" DateCreated="2023-12-30">
        <ClinVarSubmissionID localKey="NM_000126.4:c.963+1del|OMIM:231680" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004194720" DateUpdated="2023-12-30" DateCreated="2023-12-30" Type="SCV" Version="1" SubmitterName="Baylor Genetics" OrgID="1006" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-10-06">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000126.4:c.963+1del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="231680" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13856327</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="7841394" TraitType="Disease" MappingType="XRef" MappingValue="231680" MappingRef="OMIM">
        <MedGen CUI="C0268596" Name="Multiple acyl-CoA dehydrogenase deficiency" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7183343" TraitType="Disease" MappingType="XRef" MappingValue="CN169374" MappingRef="MedGen">
        <MedGen CUI="CN169374" Name="not specified" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5463935" TraitType="Disease" MappingType="XRef" MappingValue="231680" MappingRef="OMIM">
        <MedGen CUI="C0268596" Name="Multiple acyl-CoA dehydrogenase deficiency" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="22873" TraitType="Disease" MappingType="Name" MappingValue="GLUTARIC ACIDEMIA IIA" MappingRef="Preferred">
        <MedGen CUI="C3278154" Name="Glutaric acidemia IIa" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="6131508" TraitType="Disease" MappingType="XRef" MappingValue="C0268596" MappingRef="MedGen">
        <MedGen CUI="C0268596" Name="Multiple acyl-CoA dehydrogenase deficiency" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

